Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.


Player Avatar NechesInvst (99.61) Submitted: 3/6/2013 1:48:42 PM : Outperform Start Price: $29.39 QCOR Score: +82.43

In hopes that the government investigation won't amount to much, and looking at a drug company with no debt and two drugs on the market...I'm hopeful for the best. Target: 65-80 price 3 to 4 years out.

Featured Broker Partners